Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Labrecque

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Journal of Biological Chemistry|January 28, 2003
Natriuretic peptide receptor A activation stabilizes a membrane-distal dimer interfaceAndré De Léan, Normand McNicoll, Jean Labrecque
The Biochemical Journal|February 7, 2002
Allotopic antagonism of the non-peptide atrial natriuretic peptide (ANP) antagonist HS-142-1 on natriuretic peptide receptor NPR-AHugo Poirier, Jean Labrecque, Julie Deschênes, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2009
A time-resolved fluorescent lanthanide (Eu)-GTP binding assay for chemokine receptors as targets in drug discoveryJean Labrecque, Rebecca S Y Wong, Simon P Fricker
The Journal of Biological Chemistry|March 14, 2015
Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue: ROLE OF ILE198Gloria Lau, Jean Labrecque, Markus Metz, et al.
Assay and Drug Development Technologies|January 28, 2006
The development of an europium-GTP assay to quantitate chemokine antagonist interactions for CXCR4 and CCR5Jean Labrecque, Virginia Anastassov, Gloria Lau, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2014
Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)benzamides as TRPA1 antagonistsSébastien Laliberté, Frédéric Vallée, Pierre-André Fournier, et al.
Molecular Pharmacology|September 5, 2008
Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitorsRebecca S Y Wong, Veronique Bodart, Markus Metz, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2014
Discovery of a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine and a 1-aryloxyisoquinoline series of TRPA1 antagonistsYun-Jin Hu, Miguel St-Onge, Sébastien Laliberté, et al.
Blood|August 18, 2005
Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation modelLauri Burroughs, Marco Mielcarek, Marie-Térèse Little, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2013
RARα-PLZF oncogene inhibits C/EBPα function in myeloid cellsNathalie Girard, Mathieu Tremblay, Magali Humbert, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Journal of Biological Chemistry|January 28, 2003
Natriuretic peptide receptor A activation stabilizes a membrane-distal dimer interfaceAndré De Léan, Normand McNicoll, Jean Labrecque
The Biochemical Journal|February 7, 2002
Allotopic antagonism of the non-peptide atrial natriuretic peptide (ANP) antagonist HS-142-1 on natriuretic peptide receptor NPR-AHugo Poirier, Jean Labrecque, Julie Deschênes, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 11, 2009
A time-resolved fluorescent lanthanide (Eu)-GTP binding assay for chemokine receptors as targets in drug discoveryJean Labrecque, Rebecca S Y Wong, Simon P Fricker
The Journal of Biological Chemistry|March 14, 2015
Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue: ROLE OF ILE198Gloria Lau, Jean Labrecque, Markus Metz, et al.
Assay and Drug Development Technologies|January 28, 2006
The development of an europium-GTP assay to quantitate chemokine antagonist interactions for CXCR4 and CCR5Jean Labrecque, Virginia Anastassov, Gloria Lau, et al.
Bioorganic & Medicinal Chemistry Letters|June 2, 2014
Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)benzamides as TRPA1 antagonistsSébastien Laliberté, Frédéric Vallée, Pierre-André Fournier, et al.
Molecular Pharmacology|September 5, 2008
Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitorsRebecca S Y Wong, Veronique Bodart, Markus Metz, et al.
Bioorganic & Medicinal Chemistry Letters|May 20, 2014
Discovery of a 4-aryloxy-1H-pyrrolo[3,2-c]pyridine and a 1-aryloxyisoquinoline series of TRPA1 antagonistsYun-Jin Hu, Miguel St-Onge, Sébastien Laliberté, et al.
Blood|August 18, 2005
Durable engraftment of AMD3100-mobilized autologous and allogeneic peripheral-blood mononuclear cells in a canine transplantation modelLauri Burroughs, Marco Mielcarek, Marie-Térèse Little, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2013
RARα-PLZF oncogene inhibits C/EBPα function in myeloid cellsNathalie Girard, Mathieu Tremblay, Magali Humbert, et al.
Pageof 2